Recombinant YeaL is produced under optimized conditions:
Reconstitution: Lyophilized powder reconstituted in sterile water (0.1–1.0 mg/mL) with 5–50% glycerol for stability
Storage: Lyophilized form stable for 12 months at -80°C; liquid form stable for 6 months at -20°C
OMPs are promising vaccine candidates due to their surface exposure and antigenicity. For instance:
Recombinant YeaL could serve as a component of subunit vaccines targeting S. Heidelberg, a serovar linked to foodborne outbreaks .
S. Heidelberg strains carrying plasmids with AMR genes (e.g., blaOXA-48 for carbapenem resistance) highlight the need for novel therapeutic targets like YeaL .
YeaL is highly conserved in Salmonella:
| Serovar | UniProt ID | Strain | Sequence Identity |
|---|---|---|---|
| S. Heidelberg | B4TFR0 | SL476 | 100% (reference) |
| S. Dublin | B5FJH1 | CT_02021853 | 99.3% |
| S. Paratyphi B | A9N2A7 | ATCC 9150 / SARB42 | 98.9% |
| S. Typhi | Q8Z6E5 | CT18/Ty2 | 97.6% |
Mechanistic Studies: The exact role of YeaL in membrane dynamics or virulence requires further investigation.
In Vivo Models: Efficacy testing of YeaL-based vaccines in animal models is needed.
Structural Biology: High-resolution structures of YeaL could clarify its interactions with host immune components .
KEGG: seh:SeHA_C1406
The UPF0756 membrane protein YeaL is a 148-amino acid transmembrane protein initially characterized in Escherichia coli, with homologous proteins found in Salmonella species including S. heidelberg . While its precise function remains under investigation, researchers have identified it as a potential contributor to bacterial membrane integrity and possibly antibiotic resistance mechanisms.
To study this protein, researchers typically employ recombinant DNA technology to express the yeaL gene in controlled systems. The methodological approach involves:
Gene amplification using PCR with primers specific to the yeaL sequence
Cloning into expression vectors with appropriate promoters and affinity tags
Transformation into expression hosts (typically E. coli)
Induction of protein expression and subsequent purification
Structural analysis through computational modeling techniques has provided insights into YeaL's potential functional domains, with a global confidence score (pLDDT) of 84.87 indicating a relatively reliable structural prediction .
S. heidelberg has emerged as a clinically significant serovar due to its distinctive antimicrobial resistance profile. Most clinical isolates (88%) demonstrate resistance or reduced susceptibility to antibiotics from five or more antibiotic classes, including first-line treatments for severe salmonellosis such as ampicillin, ceftriaxone, and ciprofloxacin .
The methodological approach to characterizing these resistance profiles includes:
Isolation and culture of S. heidelberg from clinical or environmental samples
Antimicrobial susceptibility testing using standardized methods (disc diffusion or broth microdilution)
Whole genome sequencing to identify resistance genes
PFGE (pulsed-field gel electrophoresis) pattern analysis to establish strain relationships
Historical context is important: S. heidelberg was first identified in 1933 following a human outbreak in Heidelberg, Germany, and has since been associated with multidrug-resistant outbreaks globally, including recent incidents linked to poultry and dairy cattle in the United States .
For researchers working with membrane proteins like YeaL from S. heidelberg, a systematic approach is essential:
Bacterial culture optimization:
Grow S. heidelberg under conditions that promote expression of the target protein
Consider induction methods if working with recombinant systems
Membrane fraction isolation:
Cell lysis by methods that preserve membrane integrity (sonication or French press)
Differential centrifugation to separate membrane fractions
Density gradient ultracentrifugation for further purification
Protein extraction and solubilization:
Selection of appropriate detergents (e.g., DDM, LDAO, or Triton X-100)
Optimization of detergent concentration and buffer conditions
Maintaining protein stability during solubilization
Purification strategies:
Affinity chromatography (if tagged recombinant protein)
Ion exchange chromatography
Size exclusion chromatography
Characterization techniques:
The dfrA34 gene represents a novel mechanism of trimethoprim resistance in S. heidelberg, identified during a multistate outbreak investigation by the CDC in 2017 . This gene encodes a dihydrofolate reductase variant that shares less than 50% amino acid identity with previously reported dfrA variants.
The functional characterization methodology included:
Cloning the 588 bp putative dfr gene from S. heidelberg isolate 2016K-0796
Transforming it into E. coli
Measuring trimethoprim MIC values in resulting transformants (≥2 mg/L) compared to control strains with empty vectors (0.5 mg/L)
Notably, genomic analysis revealed that dfrA34 is invariably found alongside the sul1 gene, creating a genetic arrangement that confers clinical trimethoprim/sulfamethoxazole resistance . The genetic context includes a 5533 bp region containing dfrA34, ISCR1, and the 3′-CS (sul1).
While direct interactions between dfrA34 and membrane proteins like YeaL have not been definitively established, their potential relationship is of interest because:
Membrane proteins often influence drug efflux and cellular permeability
Genetic elements carrying resistance genes may co-localize with membrane protein-encoding regions
Mobile genetic elements containing resistance determinants can affect membrane protein expression
Plasmids serve as critical vectors for antimicrobial resistance dissemination in S. heidelberg, with distinct implications for membrane protein expression and function. Research has identified several key plasmid types associated with resistance:
IncI1 plasmids harboring the bla<sub>CMY-2</sub> gene (conferring beta-lactam resistance)
IncC plasmids carrying multiple resistance genes including floR, cmlA1, tet(A), bla<sub>TEM-1B</sub>, ant(2′′)-Ia, aph(6)-Id, aph(3′′)-Ib, and sul2
Col plasmids, which may influence bacterial persistence in environmental conditions
A methodological investigation of plasmid dynamics demonstrated that:
S. heidelberg strains carrying higher copy numbers of small Col plasmids demonstrated enhanced survival in environmental conditions
Strains harboring transmissible plasmids with AmpC-like beta-lactamase genes persisted longer without antibiotic selection pressure
Mobile genetic elements, including plasmids and bacteriophages, played significant roles in S. heidelberg persistence
The potential influence on membrane proteins stems from the observation that:
Plasmid acquisition can alter bacterial membrane composition and permeability
Expression of plasmid-encoded proteins may compete with or regulate chromosomally-encoded membrane proteins
Selective pressures that maintain plasmids may co-select for alterations in membrane protein expression
Whole genome sequencing (WGS) has revolutionized the investigation of S. heidelberg outbreaks and the characterization of its resistance mechanisms. During the multidrug-resistant S. heidelberg outbreak linked to dairy calves, WGS played a pivotal role by:
Demonstrating close genetic relatedness between human and animal isolates, confirming the zoonotic transmission route
Identifying seven specific PFGE patterns associated with the outbreak strains
Detecting genetic determinants of resistance that correlated with observed phenotypic resistance profiles
The methodological workflow for WGS-based investigation includes:
DNA extraction from pure bacterial cultures
Library preparation and sequencing (typically using Illumina technology)
De novo assembly or reference-based alignment
Annotation and identification of resistance genes, virulence factors, and mobile genetic elements
Phylogenetic analysis to establish relationships between isolates
This approach has enabled researchers to:
Predict antimicrobial resistance from genetic markers with high accuracy
Identify novel resistance determinants like dfrA34
Understand the genetic context of resistance genes, including their association with mobile genetic elements
Track the evolution and spread of specific resistant clones
Investigating membrane protein function in S. heidelberg requires careful experimental design that addresses the specific challenges of these proteins. The following methodological framework is recommended:
As noted in experimental design literature: "A good experimental design is characterized by the absence of systematic error. Experimental units should not differ in any systematic way from one another."
To investigate potential associations between antimicrobial resistance and membrane protein changes in S. heidelberg, researchers should employ a multifaceted approach:
Comparative genomics and transcriptomics:
Protein expression analysis:
Quantify membrane protein expression levels in resistant vs. susceptible strains
Investigate post-translational modifications
Examine membrane proteome changes following acquisition of resistance plasmids
Functional characterization:
Generate yeaL knockout mutants and assess antimicrobial susceptibility profiles
Complement with wild-type and modified versions of the gene
Measure membrane permeability and drug accumulation
Structural biology approaches:
Evolutionary analysis:
Track membrane protein sequence evolution alongside resistance development
Examine selection pressures on membrane protein genes in resistant lineages
Analyze horizontal gene transfer events affecting membrane protein genes and resistance determinants
| Experimental Approach | Advantages | Limitations | Application to YeaL Research |
|---|---|---|---|
| Gene knockout | Direct assessment of function | Potential compensatory mechanisms | Determine essentiality and resistance contribution |
| Recombinant expression | Controlled protein production | May not reflect native conditions | Structural and biochemical characterization |
| Transcriptomics | Genome-wide expression patterns | mRNA≠protein levels | Identify co-regulated genes and stress responses |
| Proteomics | Direct protein quantification | Membrane protein extraction challenges | Map YeaL interactions and modifications |
| Structural analysis | Insight into mechanism | Computational models need validation | Identify functional domains and binding sites |
S. heidelberg demonstrates remarkable environmental persistence, with studies showing survival for up to 21 days in pine wood shavings (PWS) commonly used as broiler bedding . This persistence has significant implications for disease transmission and outbreak control.
The methodological approach to investigating these survival mechanisms involves:
Environmental challenge studies:
Inoculation of bacterial strains into relevant environmental matrices
Temporal sampling to track survival kinetics
Correlation analysis between environmental parameters and bacterial persistence
Genetic determinant analysis:
Comparison of persistent vs. non-persistent strains
Identification of genetic elements associated with survival
Investigation of plasmid and bacteriophage roles in persistence
Research has revealed several key findings:
S. heidelberg abundance decreases by approximately 4.4 Log<sub>10</sub> CFU/g over 21 days in PWS
Water activity of the substrate correlates with S. heidelberg survival
Strains carrying specific plasmids (notably, those with higher copy numbers of Col plasmids) demonstrate enhanced environmental persistence
Bacteriophage acquisition can occur between strains in environmental settings, potentially conferring survival advantages
Membrane proteins likely contribute to environmental persistence through:
Maintaining cellular integrity under desiccation stress
Regulating osmotic balance in variable moisture conditions
Facilitating nutrient acquisition in nutrient-limited environments
Potentially participating in biofilm formation on environmental surfaces
The emergence of multidrug-resistant S. heidelberg strains with resistance to first-line treatments necessitates exploration of novel antimicrobial targets, with membrane proteins representing promising candidates. Current methodological approaches include:
Structure-based drug design:
Functional inhibition strategies:
Identification of critical residues through site-directed mutagenesis
Development of peptidomimetics that disrupt protein-protein interactions
Small molecule screening for functional inhibitors
Combination approaches:
Targeting membrane proteins alongside established antimicrobial targets
Developing adjuvants that enhance existing antibiotic efficacy by interfering with membrane protein function
Exploiting synergistic effects between membrane disruption and other antimicrobial mechanisms
Alternative therapeutic modalities:
Antimicrobial peptides targeting membrane structure
Bacteriophage-based approaches
Immunomodulatory strategies that enhance host defense mechanisms
Researchers must consider the challenges inherent in targeting membrane proteins, including the need for compounds that can access the bacterial membrane, specificity to avoid host toxicity, and the potential for resistance development.
Understanding the dynamic expression and function of membrane proteins like YeaL during the infection process requires investigation of host-pathogen interactions. The methodological framework includes:
In vivo expression analysis:
Animal infection models to track gene expression in different host niches
Ex vivo studies using host-derived fluids or cell cultures
RNA-seq and proteomics to monitor temporal changes in expression
Environmental sensing mechanisms:
Investigation of regulatory networks controlling yeaL expression
Characterization of response to environmental signals (pH, antimicrobials, nutrient availability)
Identification of transcription factors and small RNAs influencing expression
Host interaction studies:
Examination of YeaL's role in adhesion to host cells
Assessment of immunogenic properties
Investigation of potential interactions with host defense mechanisms
Infection stage-specific functions:
Analysis of YeaL contribution to initial colonization
Evaluation of role in invasion and intracellular survival
Assessment of importance during persistent infection
Research on related pathogens suggests that membrane protein expression patterns shift significantly during the transition from environmental reservoirs to host environments, which may explain the observation that strains with certain plasmid profiles demonstrate enhanced persistence both in the environment and during infection .
Recombinant expression of membrane proteins presents unique challenges due to their hydrophobic nature and complex folding requirements. For S. heidelberg membrane proteins like YeaL, researchers must navigate several technical hurdles:
Expression system selection challenges:
Bacterial systems may struggle with proper membrane insertion
Eukaryotic systems may introduce inappropriate post-translational modifications
Cell-free systems often yield insufficient quantities
Solution methodology: Screen multiple expression systems (E. coli, yeast, insect cells) with different promoters and induction conditions; consider membrane-targeted expression systems specifically designed for membrane proteins.
Protein folding and stability issues:
Misfolding and aggregation are common
Toxicity to host cells can limit expression
Native structure may depend on specific lipid environments
Solution methodology: Optimize growth temperature (often lower temperatures improve folding); introduce fusion partners that enhance solubility; co-express chaperones; develop detergent screening protocols to identify optimal solubilization conditions.
Purification challenges:
Detergent selection affects protein stability and activity
Maintaining proper folding throughout purification
Achieving sufficient purity without compromising function
Solution methodology: Implement systematic detergent screening; utilize lipid nanodiscs or amphipols as alternatives to detergents; develop streamlined purification protocols that minimize exposure to harsh conditions.
Functional characterization difficulties:
Traditional assays may not work in detergent solutions
Reconstitution into membranes can be inefficient
Activity may depend on specific lipid composition
Solution methodology: Develop liposome reconstitution protocols; establish solid-supported membrane electrophysiology; implement label-free binding assays compatible with detergent environments.
| Challenge | Traditional Approach | Improved Methodology | Application to YeaL |
|---|---|---|---|
| Low expression | Strong promoters, high inducer | Mild induction, lower temperature | Optimize expression conditions based on growth curves |
| Protein aggregation | Denaturing and refolding | Fusion tags, specialized hosts | Test multiple solubility tags (MBP, SUMO) |
| Detergent compatibility | Trial and error | Systematic detergent screening | Develop stability assay across detergent panel |
| Functional assessment | Simplified in vitro assays | Reconstitution into native-like environments | Establish proteoliposome systems |
Systems biology offers powerful frameworks for understanding complex biological processes in antimicrobial-resistant S. heidelberg, particularly regarding membrane protein networks. Methodological approaches include:
Multi-omics integration:
Combine genomics, transcriptomics, proteomics, and metabolomics data
Develop computational models of membrane protein interactions
Identify emergent properties not evident from single-omics approaches
Network analysis methods:
Construct protein-protein interaction networks centered on YeaL
Identify hub proteins and critical nodes in membrane protein networks
Compare network architectures between susceptible and resistant strains
Flux balance analysis:
Model metabolic networks influenced by membrane transporters
Predict metabolic adaptations following antimicrobial exposure
Identify vulnerable nodes as potential therapeutic targets
Machine learning applications:
Develop predictive models for resistance emergence
Identify patterns linking membrane protein variations to phenotypic outcomes
Optimize experimental design through active learning approaches
These advanced approaches could reveal how membrane proteins like YeaL participate in broader cellular networks that contribute to antimicrobial resistance, environmental persistence, and virulence, potentially identifying new intervention strategies.
Research involving recombinant antimicrobial-resistant S. heidelberg presents significant biosafety and ethical considerations that must be addressed through rigorous protocols:
Risk assessment methodology:
Evaluate both inherent pathogen risks and those associated with genetic modifications
Consider the potential consequences of horizontal gene transfer
Assess risks specifically related to creating strains with modified membrane proteins
Containment strategies:
Implement appropriate Biosafety Level (BSL) practices (typically BSL-2 with enhanced measures)
Establish specific protocols for handling multidrug-resistant strains
Develop strain-specific inactivation procedures and validate their effectiveness
Genetic safeguards:
Consider auxotrophic markers to limit environmental survival
Implement conditional expression systems when possible
Avoid unnecessary antibiotic resistance markers
Ethical review procedures:
Obtain appropriate institutional biosafety committee approvals
Document scientific justification for creating recombinant strains
Ensure research benefits outweigh potential risks
Data sharing considerations:
Develop protocols for responsible sharing of potentially sensitive data
Consider dual-use research implications
Balance transparency with security concerns
Given that S. heidelberg has been associated with significant outbreaks , researchers must be particularly vigilant when working with strains that may combine enhanced antimicrobial resistance with potential modifications to membrane proteins that could affect virulence or environmental persistence.
Structural biology techniques offer unprecedented insights into membrane protein function, with several methodological approaches applicable to understanding YeaL in S. heidelberg:
Cryo-electron microscopy (cryo-EM) approaches:
Single-particle analysis for high-resolution structure determination
Tomography to visualize YeaL in its native membrane context
Time-resolved studies to capture conformational changes
Advanced computational methods:
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Probe protein dynamics and solvent accessibility
Identify regions involved in ligand binding
Map conformational changes upon substrate interaction
Solid-state NMR techniques:
Determine membrane protein structure in lipid environments
Investigate protein-lipid interactions
Characterize dynamic processes on different timescales
Integrative structural biology:
Combine multiple experimental techniques (X-ray crystallography, NMR, cryo-EM)
Develop hybrid models incorporating diverse structural data
Validate computational predictions with experimental constraints
These approaches would significantly advance our understanding of YeaL's molecular mechanism, potentially revealing:
How its structure relates to antimicrobial resistance phenotypes
Structural changes that occur during environmental persistence
Potential binding sites for novel antimicrobial compounds